. "Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project" . . "Sans, Miquel" . . . "http://dx.doi.org/10.1136/gutjnl-2011-300777" . "Pena, Salvador Amado" . . . "Szczypiorska, Magdalena" . "[3AA7B52B8C1D]" . "Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project"@en . "Artieda, Marta" . "Project.; European; IBDchip; results; phenotype; disease; influence; also; Crohns; develop; susceptibility; increased; conferring; factors; Genetic"@en . . "Cleynen, Isabelle" . "10"^^ . "11" . "Objective Through genome-wide association scans and meta-analyses thereof, over 70 genetic loci (Crohn's disease (CD) single nucleotide polymorphisms (SNPs)) are significantly associated with CD. We aimed to investigate the influence of CD-SNPs and basic patient characteristics on CD clinical course, and develop statistical models to predict CD clinical course. Design This retrospective study included 1528 patients with CD with more than 10 years of follow-up from eight European referral hospitals. CD outcomes of interest were ileal (L1), colonic (L2) and ileocolonic disease location (L3); stenosing (B2) or penetrating behaviour (B3); perianal disease; extraintestinal manifestations; and bowel resection. A complicated disease course was defined as stenosing or penetrating behaviour, perianal disease and/or bowel resection. Association between CD-SNPs or patient characteristics and specified outcomes was studied. Conclusions This large multicentre cohort study has found several genetic and clinical factors influencing the clinical course of CD. NOD2 and early immunomodulator use are the clinically most meaningful predictors for its clinical course." . "62" . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . "0017-5749" . "N" . "Arteta, David" . . "Vermeire, Severine" . "76386" . . "Ayala, Edgar" . "Jewell, Derek P." . . "2"^^ . "Gonzalez, Juan R." . "Franke, Andre" . "11110" . "RIV/00216208:11110/13:10193649!RIV14-MSM-11110___" . "Danese, Silvio" . . "McGovern, Dermot" . "Bortl\u00EDk, Martin" . . . . "Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project" . . "Figueroa, Carolina" . . "Luk\u00E1\u0161, Milan" . "Vecchi, Maurizio" . "Bethge, Johannes" . . "10.1136/gutjnl-2011-300777" . "Crusius, Bart J. A." . . "Panes, Julian" . "Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project"@en . "Gut" . . "000325557200007" . . . "RIV/00216208:11110/13:10193649" . . . . "Objective Through genome-wide association scans and meta-analyses thereof, over 70 genetic loci (Crohn's disease (CD) single nucleotide polymorphisms (SNPs)) are significantly associated with CD. We aimed to investigate the influence of CD-SNPs and basic patient characteristics on CD clinical course, and develop statistical models to predict CD clinical course. Design This retrospective study included 1528 patients with CD with more than 10 years of follow-up from eight European referral hospitals. CD outcomes of interest were ileal (L1), colonic (L2) and ileocolonic disease location (L3); stenosing (B2) or penetrating behaviour (B3); perianal disease; extraintestinal manifestations; and bowel resection. A complicated disease course was defined as stenosing or penetrating behaviour, perianal disease and/or bowel resection. Association between CD-SNPs or patient characteristics and specified outcomes was studied. Conclusions This large multicentre cohort study has found several genetic and clinical factors influencing the clinical course of CD. NOD2 and early immunomodulator use are the clinically most meaningful predictors for its clinical course."@en . . "van Hogezand, Ruud A." . "Schreiber, Stefan" . . . . "22"^^ .